Chapter/Section Purchase

1 Study Coverage
1.1 Passive Transdermal Drug Delivery Product Introduction
1.2 Market by Type
1.2.1 Global Passive Transdermal Drug Delivery Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Microfluidics
1.2.3 Smart Pill Technology (SPT)
1.3 Market by Application
1.3.1 Global Passive Transdermal Drug Delivery Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Passive Transdermal Drug Delivery Sales Estimates and Forecasts 2017-2028
2.2 Global Passive Transdermal Drug Delivery Revenue Estimates and Forecasts 2017-2028
2.3 Global Passive Transdermal Drug Delivery Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Passive Transdermal Drug Delivery Sales by Region
2.4.1 Global Passive Transdermal Drug Delivery Sales by Region (2017-2022)
2.4.2 Global Sales Passive Transdermal Drug Delivery by Region (2023-2028)
2.5 Global Passive Transdermal Drug Delivery Revenue by Region
2.5.1 Global Passive Transdermal Drug Delivery Revenue by Region (2017-2022)
2.5.2 Global Passive Transdermal Drug Delivery Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Passive Transdermal Drug Delivery Sales by Manufacturers
3.1.1 Global Top Passive Transdermal Drug Delivery Manufacturers by Sales (2017-2022)
3.1.2 Global Passive Transdermal Drug Delivery Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Passive Transdermal Drug Delivery in 2021
3.2 Global Passive Transdermal Drug Delivery Revenue by Manufacturers
3.2.1 Global Passive Transdermal Drug Delivery Revenue by Manufacturers (2017-2022)
3.2.2 Global Passive Transdermal Drug Delivery Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Passive Transdermal Drug Delivery Revenue in 2021
3.3 Global Passive Transdermal Drug Delivery Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Passive Transdermal Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Passive Transdermal Drug Delivery Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Passive Transdermal Drug Delivery Sales by Type
4.1.1 Global Passive Transdermal Drug Delivery Historical Sales by Type (2017-2022)
4.1.2 Global Passive Transdermal Drug Delivery Forecasted Sales by Type (2023-2028)
4.1.3 Global Passive Transdermal Drug Delivery Sales Market Share by Type (2017-2028)
4.2 Global Passive Transdermal Drug Delivery Revenue by Type
4.2.1 Global Passive Transdermal Drug Delivery Historical Revenue by Type (2017-2022)
4.2.2 Global Passive Transdermal Drug Delivery Forecasted Revenue by Type (2023-2028)
4.2.3 Global Passive Transdermal Drug Delivery Revenue Market Share by Type (2017-2028)
4.3 Global Passive Transdermal Drug Delivery Price by Type
4.3.1 Global Passive Transdermal Drug Delivery Price by Type (2017-2022)
4.3.2 Global Passive Transdermal Drug Delivery Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Passive Transdermal Drug Delivery Sales by Application
5.1.1 Global Passive Transdermal Drug Delivery Historical Sales by Application (2017-2022)
5.1.2 Global Passive Transdermal Drug Delivery Forecasted Sales by Application (2023-2028)
5.1.3 Global Passive Transdermal Drug Delivery Sales Market Share by Application (2017-2028)
5.2 Global Passive Transdermal Drug Delivery Revenue by Application
5.2.1 Global Passive Transdermal Drug Delivery Historical Revenue by Application (2017-2022)
5.2.2 Global Passive Transdermal Drug Delivery Forecasted Revenue by Application (2023-2028)
5.2.3 Global Passive Transdermal Drug Delivery Revenue Market Share by Application (2017-2028)
5.3 Global Passive Transdermal Drug Delivery Price by Application
5.3.1 Global Passive Transdermal Drug Delivery Price by Application (2017-2022)
5.3.2 Global Passive Transdermal Drug Delivery Price Forecast by Application (2023-2028)
6 North America
6.1 North America Passive Transdermal Drug Delivery Market Size by Type
6.1.1 North America Passive Transdermal Drug Delivery Sales by Type (2017-2028)
6.1.2 North America Passive Transdermal Drug Delivery Revenue by Type (2017-2028)
6.2 North America Passive Transdermal Drug Delivery Market Size by Application
6.2.1 North America Passive Transdermal Drug Delivery Sales by Application (2017-2028)
6.2.2 North America Passive Transdermal Drug Delivery Revenue by Application (2017-2028)
6.3 North America Passive Transdermal Drug Delivery Market Size by Country
6.3.1 North America Passive Transdermal Drug Delivery Sales by Country (2017-2028)
6.3.2 North America Passive Transdermal Drug Delivery Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Passive Transdermal Drug Delivery Market Size by Type
7.1.1 Europe Passive Transdermal Drug Delivery Sales by Type (2017-2028)
7.1.2 Europe Passive Transdermal Drug Delivery Revenue by Type (2017-2028)
7.2 Europe Passive Transdermal Drug Delivery Market Size by Application
7.2.1 Europe Passive Transdermal Drug Delivery Sales by Application (2017-2028)
7.2.2 Europe Passive Transdermal Drug Delivery Revenue by Application (2017-2028)
7.3 Europe Passive Transdermal Drug Delivery Market Size by Country
7.3.1 Europe Passive Transdermal Drug Delivery Sales by Country (2017-2028)
7.3.2 Europe Passive Transdermal Drug Delivery Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Passive Transdermal Drug Delivery Market Size by Type
8.1.1 Asia Pacific Passive Transdermal Drug Delivery Sales by Type (2017-2028)
8.1.2 Asia Pacific Passive Transdermal Drug Delivery Revenue by Type (2017-2028)
8.2 Asia Pacific Passive Transdermal Drug Delivery Market Size by Application
8.2.1 Asia Pacific Passive Transdermal Drug Delivery Sales by Application (2017-2028)
8.2.2 Asia Pacific Passive Transdermal Drug Delivery Revenue by Application (2017-2028)
8.3 Asia Pacific Passive Transdermal Drug Delivery Market Size by Region
8.3.1 Asia Pacific Passive Transdermal Drug Delivery Sales by Region (2017-2028)
8.3.2 Asia Pacific Passive Transdermal Drug Delivery Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Passive Transdermal Drug Delivery Market Size by Type
9.1.1 Latin America Passive Transdermal Drug Delivery Sales by Type (2017-2028)
9.1.2 Latin America Passive Transdermal Drug Delivery Revenue by Type (2017-2028)
9.2 Latin America Passive Transdermal Drug Delivery Market Size by Application
9.2.1 Latin America Passive Transdermal Drug Delivery Sales by Application (2017-2028)
9.2.2 Latin America Passive Transdermal Drug Delivery Revenue by Application (2017-2028)
9.3 Latin America Passive Transdermal Drug Delivery Market Size by Country
9.3.1 Latin America Passive Transdermal Drug Delivery Sales by Country (2017-2028)
9.3.2 Latin America Passive Transdermal Drug Delivery Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Passive Transdermal Drug Delivery Market Size by Type
10.1.1 Middle East and Africa Passive Transdermal Drug Delivery Sales by Type (2017-2028)
10.1.2 Middle East and Africa Passive Transdermal Drug Delivery Revenue by Type (2017-2028)
10.2 Middle East and Africa Passive Transdermal Drug Delivery Market Size by Application
10.2.1 Middle East and Africa Passive Transdermal Drug Delivery Sales by Application (2017-2028)
10.2.2 Middle East and Africa Passive Transdermal Drug Delivery Revenue by Application (2017-2028)
10.3 Middle East and Africa Passive Transdermal Drug Delivery Market Size by Country
10.3.1 Middle East and Africa Passive Transdermal Drug Delivery Sales by Country (2017-2028)
10.3.2 Middle East and Africa Passive Transdermal Drug Delivery Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 3M
11.1.1 3M Corporation Information
11.1.2 3M Overview
11.1.3 3M Passive Transdermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 3M Passive Transdermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 3M Recent Developments
11.2 Actavis, Inc.
11.2.1 Actavis, Inc. Corporation Information
11.2.2 Actavis, Inc. Overview
11.2.3 Actavis, Inc. Passive Transdermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Actavis, Inc. Passive Transdermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Actavis, Inc. Recent Developments
11.3 Bayer AG
11.3.1 Bayer AG Corporation Information
11.3.2 Bayer AG Overview
11.3.3 Bayer AG Passive Transdermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bayer AG Passive Transdermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bayer AG Recent Developments
11.4 Boehringer Ingelheim GmbH
11.4.1 Boehringer Ingelheim GmbH Corporation Information
11.4.2 Boehringer Ingelheim GmbH Overview
11.4.3 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Boehringer Ingelheim GmbH Recent Developments
11.5 Corium International, Inc.
11.5.1 Corium International, Inc. Corporation Information
11.5.2 Corium International, Inc. Overview
11.5.3 Corium International, Inc. Passive Transdermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Corium International, Inc. Passive Transdermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Corium International, Inc. Recent Developments
11.6 Echo Therapeutics, Inc.
11.6.1 Echo Therapeutics, Inc. Corporation Information
11.6.2 Echo Therapeutics, Inc. Overview
11.6.3 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Echo Therapeutics, Inc. Recent Developments
11.7 GlaxoSmithKline plc
11.7.1 GlaxoSmithKline plc Corporation Information
11.7.2 GlaxoSmithKline plc Overview
11.7.3 GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 GlaxoSmithKline plc Passive Transdermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 GlaxoSmithKline plc Recent Developments
11.8 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
11.8.1 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Corporation Information
11.8.2 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Overview
11.8.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Recent Developments
11.9 Mylan N.V.
11.9.1 Mylan N.V. Corporation Information
11.9.2 Mylan N.V. Overview
11.9.3 Mylan N.V. Passive Transdermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Mylan N.V. Passive Transdermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Mylan N.V. Recent Developments
11.10 Novartis AG
11.10.1 Novartis AG Corporation Information
11.10.2 Novartis AG Overview
11.10.3 Novartis AG Passive Transdermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Novartis AG Passive Transdermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Novartis AG Recent Developments
11.11 Noven Pharmaceuticals, Inc.
11.11.1 Noven Pharmaceuticals, Inc. Corporation Information
11.11.2 Noven Pharmaceuticals, Inc. Overview
11.11.3 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Noven Pharmaceuticals, Inc. Recent Developments
11.12 Transdermal Corp.
11.12.1 Transdermal Corp. Corporation Information
11.12.2 Transdermal Corp. Overview
11.12.3 Transdermal Corp. Passive Transdermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Transdermal Corp. Passive Transdermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Transdermal Corp. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Passive Transdermal Drug Delivery Industry Chain Analysis
12.2 Passive Transdermal Drug Delivery Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Passive Transdermal Drug Delivery Production Mode & Process
12.4 Passive Transdermal Drug Delivery Sales and Marketing
12.4.1 Passive Transdermal Drug Delivery Sales Channels
12.4.2 Passive Transdermal Drug Delivery Distributors
12.5 Passive Transdermal Drug Delivery Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Passive Transdermal Drug Delivery Industry Trends
13.2 Passive Transdermal Drug Delivery Market Drivers
13.3 Passive Transdermal Drug Delivery Market Challenges
13.4 Passive Transdermal Drug Delivery Market Restraints
14 Key Findings in The Global Passive Transdermal Drug Delivery Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer